The reaction of 5-(1-adamantyl)-4-amino-3-mercapto-1,2,4-triazole (5) with various aromatic aldehydes in ethanol or acetic acid yielded the corresponding 4-arylideneamino derivatives 6a-v. Treatment of the 4-(2,6-difluoro-and dichlorobenzylideneamino) derivatives 6o and 6q with 1-substituted piperazines, and formaldehyde solution in ethanol afforded good yields of the corresponding 5-(1-adamantyl)-4-(2,6-dihalobenzylideneamino-2-(4-substituted-1-piperazinylmethyl)-1,2,4-triazoline-3-thiones 7a-p. 5-(1-Adamantyl)-4-arylideneamino-2-(4-ethoxycarbonyl-1-piperidylmethyl)-1,2,4-triazoline-3-thiones 8a-n, were similarly prepared via the reaction of the corresponding arylideneamino derivative with ethyl 4-piperidinecarboxylate and formaldehyde solution in ethanol. Compounds 6a-v, 7a-p and 8a-n were tested for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeastlike pathogenic fungus Candida albicans. Several derivatives showed good or moderate activities, particularly against the tested Gram-positive bacteria. In addition, the in vivo anti-inflammatory activity of 21 compounds was determined using the carrageenan-
Introduction
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used therapeutics, primarily for the treatment of pain and inflammation in arthritis. The development of microbial resistance has necessitated the search for new potent antibacterial and antifungal agents. Derivatives of adamantane which have long been known for their antiviral activity against the influenza [1] [2] [3] and HIV viruses [4] [5] [6] [7] , were also associated with central nervous [8] [9] [10] , antimicrobial [11] [12] [13] [14] [15] and antiinflammatory activities [14] [15] [16] [17] [18] . 1,2,4-Triazole derivatives were reported to possess diverse biological activities, such as antibacterial [19] [20] [21] and anti-inflammatory [22] [23] [24] [25] properties. In addition, several 5-substituted-4-arylideneamino-3-mercapto-1,2,4-triazoles and their piperazinomethyl derivatives were reported to exhibit significant antimicrobial activity [26] [27] [28] . In continuation to our interest in the chemical and pharmacological properties of adamantane derivatives [6, 11, [14] [15] [16] , we report herein the synthesis, antimicrobial and anti-inflammatory activities of a new series of 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles and their piperazinomethyl and piperidinomethyl Mannich bases.
Results and Discussion

Chemistry
5-(1-Adamantyl)-4-amino-3-mercapto-1,2,4-triazole (5) was prepared starting from adamantane-1-carboxylic acid (1) via esterification with methanol to yield the methyl ester 2, which was subsequently reacted with hydrazine to yield adamantane-1-carboxylic acid hydrazide (3) . Treatment of 3 with carbon disulphide in ethanolic potassium hydroxide yielded the corresponding potassium N'-(1-adamantylcarbonyl)dithiocarbazate (4), which was cyclized by heating with hydrazine to yield 5-(1-adamantyl)-4-amino-3-mercapto-1,2,4-triazole (5) in good overall yield [29] . Treatment of compound 5 with the appropriate aromatic aldehydes under reflux in ethanol for 5 h yielded the corresponding arylideneamino derivatives 6a-v in reasonable yields. In the cases of the reactions with 2-nitro-, 4-nitro-, 2,4-dichloro-, 3,4-dichloro-, 2,4-dinitro-, or 4,5-dimethoxy-2-nitrobenzaldehyde, the yields were very poor. This may be attributed to the poor solubility of these aldehydes in ethanol. However, carrying out the reaction in acetic acid, in which these aldehydes are freely soluble, in addition to its higher boiling point, greatly increased the yield (Scheme 1, Table 1 ).
The 2,6-difluoro-and dichlorobenzylideneamino derivatives 6o and 6q were reacted with several 1-substituted piperazines and formaldehyde solution in ethanol to yield the corresponding N-Mannich bases 7a-p in good yields. The reaction was carried out by heating the reactants in ethanol for 15 min to enhance the solubility of compounds 6o and 6q. On monitoring the reaction with thin layer chromatography (TLC), the starting compounds 6o and 6q disappeared completely after 15 minutes and the products either precipitated on standing or after addition of water. The 5-(1-adamantyl)-4-arylideneamino-2-(4-ethoxycarbonyl-1-piperidylmethyl)-1,2,4-triazoline-3-thione N-Mannich bases 8a-n were similarly prepared via the reaction of the corresponding 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazole with ethyl 4-piperidinecarboxylate and formaldehyde solution by heating the reactants in ethanol for 20 min (Scheme 2, Tables 2 and 3 ). The structures of newly synthesized compounds 6a-v, 7a-p and 8a-n were confirmed by 1 H-NMR, 13 C-NMR and mass spectra. Table 1 . Melting points, crystallization solvents, yields, molecular formulae and molecular weights of compounds 6a-v. Comp 
Antimicrobial Testing
The newly synthesized compounds 6a-v, 7a-p and 8a-n were tested for their in vitro growth inhibitory activity against the standard strains of the Institute of Fermentation of Osaka (IFO) namely; Staphylococcus aureus IFO 3060, Bacillus subtilis IFO 3007, Micrococcus luteus IFO 3232 (Grampositive bacteria), Escherichia coli IFO 3301, Pseudomonas aeuroginosa IFO 3448 (Gram-negative bacteria), and the yeast-like pathogenic fungus Candida albicans IFO 0583. The primary screening was carried out using the agar disc-diffusion method using Müller-Hinton agar medium [30] . The results of the preliminary antimicrobial testing of compounds 6a-v, 7a-p and 8a-n (200 μg/disc), the antibacterial antibiotic ampicillin trihydrate (100 μg/disc) and the antifungal drug clotrimazole (100 μg/disc) are shown in table 4. The antimicrobial activity results of the 4-arylideneaminotriazoles 6a-v revealed that the aryl substituents greatly influenced the antimicrobial activity. The halo and hydroxyl derivatives were highly active particularly against the tested Gram-positive bacteria, while the nitro and methoxy derivatives were generally inactive. In addition, the hydroxy derivatives 6g and 6h showed marked activity against the tested Gram-negative bacteria. The 4-fluoro 6c and 4-bromo 6f derivatives were significantly active against Candida albicans. Based on the antibacterial activity of the arylideneamino derivatives 6a-v, and the previously reported high chemotherapeutic activity of several 2,6-dihalophenyl derivatives [31] [32] [33] , the 2,6-difluoro-and dichlorobenzylideneamino derivatives 6o and 6q were selected to prepare their 4-substituted-1-piperazinyl Mannich bases 7a-p. The results of the antimicrobial activity of the 4-substituted-1-piperazinyl Mannich bases 7a-p were generally lower than those of the arylideneamino derivatives 6a-v but the specificity was almost similar. On the other hand, the antimicrobial activity of the 4-ethoxycarbonyl-1-piperidyl Mannich bases 8a-n was higher than the 4-substituted-1-piperazinyl Mannich bases 7a-p. The most potent member of these derivatives were the 4-hydroxybenzylidene 8f and the 3,4-dimethoxybenzylidene 8m derivatives which displayed strong broad spectrum activity. The minimal inhibitory concentration (MIC) for the most active compounds 6h, 6o, 7n, 8a, 8e, 8f and 8m against the same microorganism used in the primary screening was determined using the microdilution susceptibility method in Müller-Hinton Broth and Sabouraud Liquid Medium [34] . The MIC of the most active compounds, the antibacterial antibiotic ampicillin trihydrate and the antifungal drug clotrimazole (Table 5 ) were in accordance with the results obtained in the primary screening. 
Acute anti-inflammatory activity testing
The acute in vivo anti-inflammatory activity of 21 representative compounds (6b, 6e, 6h, 6j, 6r, 6t, 7b, 7d, 7g, 7j, 7l, 7m, 7p, 8a, 8c, 8e, 8f, 8h, 8k, 8l and 8n) was determined following the carrageenaninduced paw oedema method in rats [35] . The selection of the representative compounds and dose levels were made after carrying out pilot experiments which showed the absence of anti-inflammatory activity for some compounds and that the dose levels 20 and 40 mg/kg showed no signs of acute toxicity. The results of the anti-inflammatory activity of the tested compounds (20 & 40 mg/kg) and the potent anti-inflammatory drug Indomethacin (5 mg/kg) are listed in Table 6 . The majority of the tested compounds showed varying degrees of activity. The highest activity was shown by compound 7l, which produced strong dose-dependent inhibition of carrageenan-induced paw oedema (>50%), while compounds 7d and 8c were moderately active (30-50%) at 20 & 40 mg/kg dose level.
Compounds 7g, 7j, 8e, and 8l were moderately active at 40 mg/kg dose level and weakly active at 20 mg/kg level. The structure-anti-inflammatory activity of the tested derivatives revealed that the triazole N-2 and N-4 substituents greatly influence the anti-inflammatory activity. Table 6 . Anti-inflammatory effect of intraperitoneal injection of (20 & 40 mg/kg) of compounds 6b, 6e, 6h, 6j, 6r, 6t, 7b, 7d, 7g, 7j, 7l, 7m, 7p, 8a, 8c, 8e, 8f, 8h, 8k, 8l, 8n and Indomethacin (5 mg/kg) against carrageenan-induced paw oedema in rats. The N-2 unsubstituted adamantyltriazoles 6b, 6e, 6h, 6j, 6r and 6t were weakly active or completely inactive, while the N-2 piperazinomethyl derivatives 7b, 7d, 7g, 7j, 7l, 7m and 7p were generally active. The activity was also found to be dependent on the nature of the 4-arylideneamino and the 4-piperazinyl substituents. The activity of the 2,6-dichlorobenzylidene derivatives were slightly higher than their 2,6-difluoro-benzylidene analogues. It could be also concluded that the phenyl substituents are better compared with the ethyl, 4-fluorophenyl, 2-methoxyphenyl and benzyl substituents. The replacement of the 4-substituted-1-piperazinyl moiety with a 4-carbethoxy-1-piperidyl moiety resulted in marked decrease in activity, only the chloro derivatives 8c and 8l and the 2-hydroxy derivative 8e exhibited moderate activity. There are in fact a high number of enzyme/receptors involved in the inflammatory process. Without specific tests it is quite difficult to hypothesize the mechanism of action of the tested compounds, they may exert their action via inhibition of the cyclooxygenase enzymes like other nonsteroidal anti-inflammatory agents. In addition, the recently reported activity of some adamantane derivatives as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) [36, 37] should be taken inconsideration. The 11β-hydroxysteroid dehydrogenase type 1 converts cortisone to the active glucocorticoid cortisol, which is responsible for various metabolic disorders including water retention, thus the inhibition of 11β-HSD1 would result in increasing the intracellular cortisone level.
Experimental
General
Melting points (ºC) were measured in open glass capillaries using a Branstead 9001 Electrothermal melting point apparatus and are uncorrected. NMR spectra were obtained on a Bruker AC 500 Ultra Shield NMR spectrometer (Fällanden, Switzerland) operating at 500. 
5-(1-Adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles 6a-v
Method A: A mixture of the appropriate aromatic aldehyde (2.0 mmol) and 5-(1-adamantyl)-4-amino-3-mercapto-1,2,4-triazole (5, 0.5 g, 2.0 mmol) in absolute ethanol (10 mL) was heated under reflux for 5 h. On cooling, the separated solid was filtered, washed with cold ethanol (5 mL), dried and crystallized (Table 1) . Method B (compounds 6l, 6m, 6r, 6s, 6u and 6v): A mixture of the appropriate aromatic aldehyde (2.0 mmol) and 5-(1-adamantyl)-4-amino-3-mercapto-1,2,4-triazole (5, 0.5 g, 2 mmol) in acetic acid (8 mL) was heated under reflux for 4 h. On cooling, the separated solid was filtered, washed with cold ethanol (5 mL), dried and crystallized (Table 1) .
5-(1-Adamantyl)-4-benzylideneamino-3-mercapto-1,2,4-triazole 6a:
1 H-NMR (DMSO-d 6 ): δ 1.69- 
5-(1-Adamantyl)-4-(2,4-dichlorobenzylideneamino)-3-mercapto-1,2,4-triazole
5-(1-Adamantyl)-4-(3,4-dichlorobenzylideneamino)-3-mercapto-1,2,4-triazole
5-(1-Adamantyl)-4-(3,4-dimethoxybenzylideneamino)-3-mercapto-1,2,4-triazole
5-(1-Adamantyl)-4-(2,4-dinitrobenzylideneamino)-3-mercapto-1,2,4-triazole
5-(1-Adamantyl)-4-(4,5-dimethoxy-2-nitrobenzylideneamino)-3-mercapto-1,2,4-triazole
5-(1-Adamantyl)-4-arylideneamino-2-(4-substituted-1-piperazinylmethyl)-1,2,4-triazoline-3-thiones 7a-p
A mixture of the 5-(1-adamantyl)-4-(2,6-dihalobenzylideneamino)-3-mercapto-1,2,4-triazoles 6o or 6q (1.0 mmol), the appropriate N-substituted piperazine (1.0 mmol) and 37% formaldehyde solution (1 mL), in ethanol (8 mL), was heated under reflux for 15 min when a clear solution was obtained. Stirring was continued for 12 h at room temperature and the mixture was allowed to stand overnight. Cold water (5 mL) was added and the reaction mixture was stirred for 20 min. The precipitated crude products were filtered, washed with water, dried, and crystallized (Table 2) .
5-(1-Adamantyl)-4-(2,6-difluorobenzylideneamino)-2-(4-methyl-1-piperazinylmethyl)-1,2,4-triazoline-3-thione 7a:
1 H-NMR (CDCl (M + +1, 100). 
5-(1-Adamantyl)-4-(2,6-difluorobenzylideneamino)-2-(4-ethyl-1-piperazinylmethyl)-1,2,4-triazoline-3-
5-(1-Adamantyl)-4-(2,6-difluorobenzylideneamino)-2-(4-phenyl-1-piperazinylmethyl)-1,2,4-triazoline-3-thione
5-(1-Adamantyl)-4-(2,6-difluorobenzylideneamino)-2-[4-(4-fluorophenyl)-1-piperazinylmethyl]-1,2,4-triazoline-3-thione
5-(1-Adamantyl)-4-(2,6-difluorobenzylideneamino)-2-[4-(3-trifluoromethylphenyl)-1-piperazinylmethyl]-1,2,4-triazoline-3-thione
5-(1-Adamantyl)-4-(2,6-difluorobenzylideneamino)-2-[4-(2-methoxylphenyl)-1-piperazinylmethyl]-1,2,4-triazoline-3-thione
5-(1-Adamantyl)-4-(2,6-dichlorobenzylideneamino)-2-(4-methyl-1-piperazinylmethyl)-1,2,4-triazoline-3-thione
5-(1-Adamantyl)-4-(2,6-dichlorobenzylideneamino)-2-(4-ethyl-1-piperazinylmethyl)-1,2,4-triazoline-3-thione 7j:
5-(1-Adamantyl)-4-(2,6-dichlorobenzylideneamino)-2-(4-ethoxycarbonyl-1-piperazinylmethyl)-1,2,4-triazoline-3-thione 7k:
5-(1-Adamantyl)-4-(2,6-dichlorobenzylideneamino)-2-(4-phenyl-1-piperazinylmethyl)-1,2,4-triazoline-
5-(1-Adamantyl)-4-(2,6-dichlorobenzylideneamino)-2-[4-(4-fluorophenyl)-1-piperazinylmethyl]-1,2,4-triazoline-3-thione 7m:
5-(1-Adamantyl)-4-(2,6-dichlorobenzylideneamino)-2-[4-(3-trifluoromethylphenyl)-1-piperazinylmethyl]-1,2,4-triazoline-3-thione
5-(1-Adamantyl)-4-(2,6-dichlorobenzylideneamino)-2-[4-(2-methoxyphenyl)-1-piperazinylmethyl]-1,2,4-triazoline-3-thione
5-(1-Adamantyl)-4-arylideneamino-2-(4-ethoxycarbonyl-1-piperidylmethyl)-1,2,4-triazoline-3-thiones 8a-n
A mixture of the 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazole 6 (1.0 mmol), ethyl 4-piperidinecarboxylate (0.16 g, 1.0 mmol) and 37% formaldehyde solution (1 mL), in ethanol (8 mL), was heated under reflux for 20 min when a clear solution was obtained. Stirring was continued for 12 h at room temperature and the mixture was allowed to stand overnight. Cold water (5 mL) was added and the reaction mixture was stirred for 20 min. The precipitated crude products were filtered, washed with water, dried, and crystallized (Table 3) . 
5-(1-Adamantyl)-4-benzylideneamino-2-(4-ethoxycarbonyl-1-piperidylmethyl)-1,2,4-triazoline-3-thione 8a:
Determination of minimal inhibitory concentration (MIC).
Compounds 6h, 6o, 7n, 8a, 8e, 8f and 8m, Gentamicin, Ampicillin trihydrate and Clotrimazole were dissolved in dimethylsulphoxide at concentration of 128 μg/mL. The twofold dilutions of the solution were prepared (128, 64, 32, …, 0.5 μg/mL). The microorganism suspensions at 106 CFU/mL (colony forming unit/ml) concentrations were inoculated to the corresponding wells. The plates were incubated at 36 ºC for 24 and 48 h for the bacteria and Candida albicans, respectively. The MIC values were determined as the lowest concentration that completely inhibited visible growth of the microorganism as detected by unaided eye.
Determination of the anti-inflammatory activity. Male Sprague-Dawley rats weighing 140-190 g were maintained at room temperature (20-23 ºC) . The animals were randomly divided into 42 groups each of 5 animals. The animals were housed with food and water ad libitum and allowed to be accustomed to their environment for two days before testing. Each group was injected with the specific dose of the test compound (20 and 40 mg/kg), or Indomethacin (5 mg/kg) intraperitoneally as a uniform suspension in 1 ml of 0.5% (w/v) aqueous carboxymethyl cellulose solution, one hour before injection of 0.1 mL of carrageenan (1% solution in normal saline) into the plantar tissue of the right hind paw. The left hind paw was injected with 0.1 mL of normal saline solution. Four hours after carrageenan injection, the volume of paw oedema (mL) was determined using water plethysmometer. The percentage protection against inflammation was calculated as follows:
Where V c is the mean percentage increase in paw volume in the absence of the test compound (control) and V d is the mean percentage increase in paw volume after injection of the test compound. The values are expressed as the mean percentage reduction ± S.E.M. Statistical significance between the control and treated groups was performed using the Student "t" test.
Conclusions
In this study, new series of 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles 6a-v , the N-Mannich bases 5-(1-adamantyl)-4-arylideneamino-2-(4-substituted-1-piperazinylmethyl)-1,2,4-triazoline-3-thiones 7a-p and 5-(1-adamantyl)-4-arylideneamino-2-(4-ethoxycarbonyl-1-piperidylmethyl)-1,2,4-triazoline-3-thiones 8a-n, were synthesized and their antimicrobial and antiinflammatory activity was determined. Several of the newly synthesized derivatives displayed promising antimicrobial and anti-inflammatory activities compared to known antibacterial, antifungal and anti-inflammatory drugs. Though, the mechanism of the biological activity needs further investigations, which are in progress.
